Su497 PHARMACOKINETICS (PK), SAFETY, AND EFFICACY OF INTRAVENOUS (IV) VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE: RESULTS FROM THE PHASE 2 HUBBLE STUDY

Autor:	William R. Treem, Jeffrey S. Hyams, Ashish Suri, Siddharth Bhatia, Bartosz Korczowski, Dan Turner, Nicholas M. Croft, Parul Gulati, Harisha Kadali, Chunlin Chen, Richard A. Lirio, Stanley A. Cohen, Guillermo Rossiter, Wan Sun, Frank M. Ruemmele, Erzsébet Szakos, Kinga Kowalska-Duplaga, Promise Lawrence, Maria Rosario
Rok vydání:	2021
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Gastroenterology medicine.disease Ulcerative colitis Vedolizumab Pharmacokinetics Internal medicine medicine business medicine.drug
Zdroj:	Gastroenterology. 160:S-716
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(21)02419-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::684db021a67eb92b1490ee73d98be216 https://doi.org/10.1016/s0016-5085(21)02419-7 Zobrazit plný text záznamu